HEADER TRANSPORT PROTEIN 04-OCT-23 8UFD TITLE MULTIDRUG EFFLUX PUMP MTEFPA BOUND WITH INHIBITOR BRD8000.3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRAL MEMBRANE EFFLUX PROTEIN EFPA; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: EFPA; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS MULTIDRUG EFFLUX PUMP, EFPA, MYCOBACTERIUM, BRD8000.3, TRANSPORT KEYWDS 2 PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.WANG,M.LIAO REVDAT 1 11-SEP-24 8UFD 0 JRNL AUTH S.WANG,K.WANG,K.SONG,Z.W.LAI,P.LI,D.LI,Y.SUN,Y.MEI,C.XU, JRNL AUTH 2 M.LIAO JRNL TITL STRUCTURES OF THE MYCOBACTERIUM TUBERCULOSIS EFFLUX PUMP JRNL TITL 2 EFPA REVEAL THE MECHANISMS OF TRANSPORT AND INHIBITION. JRNL REF NAT COMMUN V. 15 7710 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 39231991 JRNL DOI 10.1038/S41467-024-51948-9 REMARK 2 REMARK 2 RESOLUTION. 3.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.260 REMARK 3 NUMBER OF PARTICLES : 52099 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8UFD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1000277999. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : 2D ARRAY REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX OF MULTIDRUG EFFLUX REMARK 245 PUMP MTEFPA WITH LIPIDS AND REMARK 245 INHIBITOR BRD8000.3 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 ALA A 3 REMARK 465 LEU A 4 REMARK 465 ASN A 5 REMARK 465 ASP A 6 REMARK 465 THR A 7 REMARK 465 GLU A 8 REMARK 465 ARG A 9 REMARK 465 ALA A 10 REMARK 465 VAL A 11 REMARK 465 ARG A 12 REMARK 465 ASN A 13 REMARK 465 TRP A 14 REMARK 465 THR A 15 REMARK 465 ALA A 16 REMARK 465 GLY A 17 REMARK 465 ARG A 18 REMARK 465 PRO A 19 REMARK 465 HIS A 20 REMARK 465 ARG A 21 REMARK 465 PRO A 22 REMARK 465 ALA A 23 REMARK 465 PRO A 24 REMARK 465 MET A 25 REMARK 465 ARG A 26 REMARK 465 PRO A 27 REMARK 465 PRO A 28 REMARK 465 ARG A 29 REMARK 465 SER A 30 REMARK 465 GLU A 31 REMARK 465 GLU A 32 REMARK 465 THR A 33 REMARK 465 ALA A 34 REMARK 465 SER A 35 REMARK 465 GLU A 36 REMARK 465 ARG A 37 REMARK 465 PRO A 38 REMARK 465 SER A 39 REMARK 465 ARG A 40 REMARK 465 TYR A 41 REMARK 465 TYR A 42 REMARK 465 PRO A 43 REMARK 465 THR A 44 REMARK 465 GLU A 520 REMARK 465 VAL A 521 REMARK 465 LYS A 522 REMARK 465 GLU A 523 REMARK 465 ALA A 524 REMARK 465 ILE A 525 REMARK 465 ASP A 526 REMARK 465 ALA A 527 REMARK 465 GLY A 528 REMARK 465 GLU A 529 REMARK 465 LEU A 530 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 ALA B 3 REMARK 465 LEU B 4 REMARK 465 ASN B 5 REMARK 465 ASP B 6 REMARK 465 THR B 7 REMARK 465 GLU B 8 REMARK 465 ARG B 9 REMARK 465 ALA B 10 REMARK 465 VAL B 11 REMARK 465 ARG B 12 REMARK 465 ASN B 13 REMARK 465 TRP B 14 REMARK 465 THR B 15 REMARK 465 ALA B 16 REMARK 465 GLY B 17 REMARK 465 ARG B 18 REMARK 465 PRO B 19 REMARK 465 HIS B 20 REMARK 465 ARG B 21 REMARK 465 PRO B 22 REMARK 465 ALA B 23 REMARK 465 PRO B 24 REMARK 465 MET B 25 REMARK 465 ARG B 26 REMARK 465 PRO B 27 REMARK 465 PRO B 28 REMARK 465 ARG B 29 REMARK 465 SER B 30 REMARK 465 GLU B 31 REMARK 465 GLU B 32 REMARK 465 THR B 33 REMARK 465 ALA B 34 REMARK 465 SER B 35 REMARK 465 GLU B 36 REMARK 465 ARG B 37 REMARK 465 PRO B 38 REMARK 465 SER B 39 REMARK 465 ARG B 40 REMARK 465 TYR B 41 REMARK 465 TYR B 42 REMARK 465 PRO B 43 REMARK 465 THR B 44 REMARK 465 GLU B 520 REMARK 465 VAL B 521 REMARK 465 LYS B 522 REMARK 465 GLU B 523 REMARK 465 ALA B 524 REMARK 465 ILE B 525 REMARK 465 ASP B 526 REMARK 465 ALA B 527 REMARK 465 GLY B 528 REMARK 465 GLU B 529 REMARK 465 LEU B 530 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 46 73.17 52.79 REMARK 500 PRO A 47 -177.08 -68.75 REMARK 500 THR A 231 -167.94 -79.70 REMARK 500 VAL A 515 -55.94 -126.16 REMARK 500 ALA A 518 -123.86 58.23 REMARK 500 LEU B 46 73.24 52.71 REMARK 500 PRO B 47 -177.12 -68.70 REMARK 500 THR B 231 -167.95 -79.67 REMARK 500 VAL B 515 -55.96 -126.11 REMARK 500 ALA B 518 -123.84 58.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PTY A 601 REMARK 610 PTY A 602 REMARK 610 PTY B 601 REMARK 610 PTY B 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8WM5 RELATED DB: PDB REMARK 900 8WM5 CONTAINS THE SAME PROTEIN COMPLEXED WITH LIPIDS REMARK 900 RELATED ID: EMD-42204 RELATED DB: EMDB REMARK 900 MULTIDRUG EFFLUX PUMP MTEFPA BOUND WITH INHIBITOR BRD8000.3 DBREF1 8UFD A 1 530 UNP A0A045GQW7_MYCTX DBREF2 8UFD A A0A045GQW7 1 530 DBREF1 8UFD B 1 530 UNP A0A045GQW7_MYCTX DBREF2 8UFD B A0A045GQW7 1 530 SEQRES 1 A 530 MET THR ALA LEU ASN ASP THR GLU ARG ALA VAL ARG ASN SEQRES 2 A 530 TRP THR ALA GLY ARG PRO HIS ARG PRO ALA PRO MET ARG SEQRES 3 A 530 PRO PRO ARG SER GLU GLU THR ALA SER GLU ARG PRO SER SEQRES 4 A 530 ARG TYR TYR PRO THR TRP LEU PRO SER ARG SER PHE ILE SEQRES 5 A 530 ALA ALA VAL ILE ALA ILE GLY GLY MET GLN LEU LEU ALA SEQRES 6 A 530 THR MET ASP SER THR VAL ALA ILE VAL ALA LEU PRO LYS SEQRES 7 A 530 ILE GLN ASN GLU LEU SER LEU SER ASP ALA GLY ARG SER SEQRES 8 A 530 TRP VAL ILE THR ALA TYR VAL LEU THR PHE GLY GLY LEU SEQRES 9 A 530 MET LEU LEU GLY GLY ARG LEU GLY ASP THR ILE GLY ARG SEQRES 10 A 530 LYS ARG THR PHE ILE VAL GLY VAL ALA LEU PHE THR ILE SEQRES 11 A 530 SER SER VAL LEU CYS ALA VAL ALA TRP ASP GLU ALA THR SEQRES 12 A 530 LEU VAL ILE ALA ARG LEU SER GLN GLY VAL GLY SER ALA SEQRES 13 A 530 ILE ALA SER PRO THR GLY LEU ALA LEU VAL ALA THR THR SEQRES 14 A 530 PHE PRO LYS GLY PRO ALA ARG ASN ALA ALA THR ALA VAL SEQRES 15 A 530 PHE ALA ALA MET THR ALA ILE GLY SER VAL MET GLY LEU SEQRES 16 A 530 VAL VAL GLY GLY ALA LEU THR GLU VAL SER TRP ARG TRP SEQRES 17 A 530 ALA PHE LEU VAL ASN VAL PRO ILE GLY LEU VAL MET ILE SEQRES 18 A 530 TYR LEU ALA ARG THR ALA LEU ARG GLU THR ASN LYS GLU SEQRES 19 A 530 ARG MET LYS LEU ASP ALA THR GLY ALA ILE LEU ALA THR SEQRES 20 A 530 LEU ALA CYS THR ALA ALA VAL PHE ALA PHE SER ILE GLY SEQRES 21 A 530 PRO GLU LYS GLY TRP MET SER GLY ILE THR ILE GLY SER SEQRES 22 A 530 GLY LEU VAL ALA LEU ALA ALA ALA VAL ALA PHE VAL ILE SEQRES 23 A 530 VAL GLU ARG THR ALA GLU ASN PRO VAL VAL PRO PHE HIS SEQRES 24 A 530 LEU PHE ARG ASP ARG ASN ARG LEU VAL THR PHE SER ALA SEQRES 25 A 530 ILE LEU LEU ALA GLY GLY VAL MET PHE SER LEU THR VAL SEQRES 26 A 530 CYS ILE GLY LEU TYR VAL GLN ASP ILE LEU GLY TYR SER SEQRES 27 A 530 ALA LEU ARG ALA GLY VAL GLY PHE ILE PRO PHE VAL ILE SEQRES 28 A 530 ALA MET GLY ILE GLY LEU GLY VAL SER SER GLN LEU VAL SEQRES 29 A 530 SER ARG PHE SER PRO ARG VAL LEU THR ILE GLY GLY GLY SEQRES 30 A 530 TYR LEU LEU PHE GLY ALA MET LEU TYR GLY SER PHE PHE SEQRES 31 A 530 MET HIS ARG GLY VAL PRO TYR PHE PRO ASN LEU VAL MET SEQRES 32 A 530 PRO ILE VAL VAL GLY GLY ILE GLY ILE GLY MET ALA VAL SEQRES 33 A 530 VAL PRO LEU THR LEU SER ALA ILE ALA GLY VAL GLY PHE SEQRES 34 A 530 ASP GLN ILE GLY PRO VAL SER ALA ILE ALA LEU MET LEU SEQRES 35 A 530 GLN SER LEU GLY GLY PRO LEU VAL LEU ALA VAL ILE GLN SEQRES 36 A 530 ALA VAL ILE THR SER ARG THR LEU TYR LEU GLY GLY THR SEQRES 37 A 530 THR GLY PRO VAL LYS PHE MET ASN ASP VAL GLN LEU ALA SEQRES 38 A 530 ALA LEU ASP HIS ALA TYR THR TYR GLY LEU LEU TRP VAL SEQRES 39 A 530 ALA GLY ALA ALA ILE ILE VAL GLY GLY MET ALA LEU PHE SEQRES 40 A 530 ILE GLY TYR THR PRO GLN GLN VAL ALA HIS ALA GLN GLU SEQRES 41 A 530 VAL LYS GLU ALA ILE ASP ALA GLY GLU LEU SEQRES 1 B 530 MET THR ALA LEU ASN ASP THR GLU ARG ALA VAL ARG ASN SEQRES 2 B 530 TRP THR ALA GLY ARG PRO HIS ARG PRO ALA PRO MET ARG SEQRES 3 B 530 PRO PRO ARG SER GLU GLU THR ALA SER GLU ARG PRO SER SEQRES 4 B 530 ARG TYR TYR PRO THR TRP LEU PRO SER ARG SER PHE ILE SEQRES 5 B 530 ALA ALA VAL ILE ALA ILE GLY GLY MET GLN LEU LEU ALA SEQRES 6 B 530 THR MET ASP SER THR VAL ALA ILE VAL ALA LEU PRO LYS SEQRES 7 B 530 ILE GLN ASN GLU LEU SER LEU SER ASP ALA GLY ARG SER SEQRES 8 B 530 TRP VAL ILE THR ALA TYR VAL LEU THR PHE GLY GLY LEU SEQRES 9 B 530 MET LEU LEU GLY GLY ARG LEU GLY ASP THR ILE GLY ARG SEQRES 10 B 530 LYS ARG THR PHE ILE VAL GLY VAL ALA LEU PHE THR ILE SEQRES 11 B 530 SER SER VAL LEU CYS ALA VAL ALA TRP ASP GLU ALA THR SEQRES 12 B 530 LEU VAL ILE ALA ARG LEU SER GLN GLY VAL GLY SER ALA SEQRES 13 B 530 ILE ALA SER PRO THR GLY LEU ALA LEU VAL ALA THR THR SEQRES 14 B 530 PHE PRO LYS GLY PRO ALA ARG ASN ALA ALA THR ALA VAL SEQRES 15 B 530 PHE ALA ALA MET THR ALA ILE GLY SER VAL MET GLY LEU SEQRES 16 B 530 VAL VAL GLY GLY ALA LEU THR GLU VAL SER TRP ARG TRP SEQRES 17 B 530 ALA PHE LEU VAL ASN VAL PRO ILE GLY LEU VAL MET ILE SEQRES 18 B 530 TYR LEU ALA ARG THR ALA LEU ARG GLU THR ASN LYS GLU SEQRES 19 B 530 ARG MET LYS LEU ASP ALA THR GLY ALA ILE LEU ALA THR SEQRES 20 B 530 LEU ALA CYS THR ALA ALA VAL PHE ALA PHE SER ILE GLY SEQRES 21 B 530 PRO GLU LYS GLY TRP MET SER GLY ILE THR ILE GLY SER SEQRES 22 B 530 GLY LEU VAL ALA LEU ALA ALA ALA VAL ALA PHE VAL ILE SEQRES 23 B 530 VAL GLU ARG THR ALA GLU ASN PRO VAL VAL PRO PHE HIS SEQRES 24 B 530 LEU PHE ARG ASP ARG ASN ARG LEU VAL THR PHE SER ALA SEQRES 25 B 530 ILE LEU LEU ALA GLY GLY VAL MET PHE SER LEU THR VAL SEQRES 26 B 530 CYS ILE GLY LEU TYR VAL GLN ASP ILE LEU GLY TYR SER SEQRES 27 B 530 ALA LEU ARG ALA GLY VAL GLY PHE ILE PRO PHE VAL ILE SEQRES 28 B 530 ALA MET GLY ILE GLY LEU GLY VAL SER SER GLN LEU VAL SEQRES 29 B 530 SER ARG PHE SER PRO ARG VAL LEU THR ILE GLY GLY GLY SEQRES 30 B 530 TYR LEU LEU PHE GLY ALA MET LEU TYR GLY SER PHE PHE SEQRES 31 B 530 MET HIS ARG GLY VAL PRO TYR PHE PRO ASN LEU VAL MET SEQRES 32 B 530 PRO ILE VAL VAL GLY GLY ILE GLY ILE GLY MET ALA VAL SEQRES 33 B 530 VAL PRO LEU THR LEU SER ALA ILE ALA GLY VAL GLY PHE SEQRES 34 B 530 ASP GLN ILE GLY PRO VAL SER ALA ILE ALA LEU MET LEU SEQRES 35 B 530 GLN SER LEU GLY GLY PRO LEU VAL LEU ALA VAL ILE GLN SEQRES 36 B 530 ALA VAL ILE THR SER ARG THR LEU TYR LEU GLY GLY THR SEQRES 37 B 530 THR GLY PRO VAL LYS PHE MET ASN ASP VAL GLN LEU ALA SEQRES 38 B 530 ALA LEU ASP HIS ALA TYR THR TYR GLY LEU LEU TRP VAL SEQRES 39 B 530 ALA GLY ALA ALA ILE ILE VAL GLY GLY MET ALA LEU PHE SEQRES 40 B 530 ILE GLY TYR THR PRO GLN GLN VAL ALA HIS ALA GLN GLU SEQRES 41 B 530 VAL LYS GLU ALA ILE ASP ALA GLY GLU LEU HET PTY A 601 40 HET PTY A 602 45 HET WJI A 603 25 HET PTY B 601 40 HET PTY B 602 45 HET WJI B 603 25 HETNAM PTY PHOSPHATIDYLETHANOLAMINE HETNAM WJI (1S,3S)-N-[6-BROMO-5-(PYRIMIDIN-2-YL)PYRIDIN-2-YL]-2,2- HETNAM 2 WJI DIMETHYL-3-(2-METHYLPROPYL)CYCLOPROPANE-1-CARBOXAMIDE FORMUL 3 PTY 4(C40 H80 N O8 P) FORMUL 5 WJI 2(C19 H23 BR N4 O) HELIX 1 AA1 SER A 48 SER A 84 1 37 HELIX 2 AA2 SER A 86 LEU A 104 1 19 HELIX 3 AA3 LEU A 104 GLY A 116 1 13 HELIX 4 AA4 GLY A 116 VAL A 137 1 22 HELIX 5 AA5 ASP A 140 THR A 169 1 30 HELIX 6 AA6 GLY A 173 LEU A 201 1 29 HELIX 7 AA7 TRP A 208 LEU A 211 5 4 HELIX 8 AA8 VAL A 212 ALA A 227 1 16 HELIX 9 AA9 ASP A 239 GLY A 264 1 26 HELIX 10 AB1 SER A 267 THR A 290 1 24 HELIX 11 AB2 PHE A 298 ARG A 302 5 5 HELIX 12 AB3 ASP A 303 ILE A 334 1 32 HELIX 13 AB4 SER A 338 SER A 365 1 28 HELIX 14 AB5 SER A 368 PHE A 390 1 23 HELIX 15 AB6 LEU A 401 ILE A 424 1 24 HELIX 16 AB7 GLN A 431 LEU A 465 1 35 HELIX 17 AB8 ASN A 476 LEU A 506 1 31 HELIX 18 AB9 PRO A 512 HIS A 517 1 6 HELIX 19 AC1 SER B 48 SER B 84 1 37 HELIX 20 AC2 SER B 86 LEU B 104 1 19 HELIX 21 AC3 LEU B 104 GLY B 116 1 13 HELIX 22 AC4 GLY B 116 VAL B 137 1 22 HELIX 23 AC5 ASP B 140 THR B 169 1 30 HELIX 24 AC6 GLY B 173 LEU B 201 1 29 HELIX 25 AC7 TRP B 208 LEU B 211 5 4 HELIX 26 AC8 VAL B 212 ALA B 227 1 16 HELIX 27 AC9 ASP B 239 GLY B 264 1 26 HELIX 28 AD1 SER B 267 THR B 290 1 24 HELIX 29 AD2 PHE B 298 ARG B 302 5 5 HELIX 30 AD3 ASP B 303 ILE B 334 1 32 HELIX 31 AD4 SER B 338 SER B 365 1 28 HELIX 32 AD5 SER B 368 PHE B 390 1 23 HELIX 33 AD6 LEU B 401 ILE B 424 1 24 HELIX 34 AD7 GLN B 431 LEU B 465 1 35 HELIX 35 AD8 ASN B 476 LEU B 506 1 31 HELIX 36 AD9 PRO B 512 HIS B 517 1 6 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000